[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"case:lead-pharma-medicine-bv-09172969:header:guest:personal:":3,"case:lead-pharma-medicine-bv-09172969:overview:guest:personal::{}":80},{"id":4,"slug":5,"name":6,"trade_names":7,"status":8,"procedure":9,"procedure_type":10,"insolvency_number":29,"case_number":29,"declared_on":30,"terminated_on":31,"termination_reason":32,"kvk_number":33,"legal_form":34,"sbi":14,"court":37,"judge":40,"judge_source":41,"curator":42,"location":46,"counts":56,"pages":61,"follower_count":60,"report_count":57,"last_report_on":73,"last_update_at":74,"freshness":75,"linked":79},"01M3SJFSJCWBFFNRZ7ERDWZQ0C","lead-pharma-medicine-bv-09172969","Lead Pharma Medicine B.V.",[],"terminated","bankruptcy",{"id":11,"key":9,"family":12,"name":13,"short_name":14,"legal_basis":15,"features":19},"01M3Y8CPCPT53NPXHK39BWK1QY","insolvency","Faillissement",null,{"name":16,"provision":17,"url":18},"Faillissementswet","Titel I (art. 1 e.v.)","https:\u002F\u002Fwetten.overheid.nl\u002FBWBR0001860",[20,21,22,23,24,25,26,27,28],"reports","financials","creditors","assets","investigations","curator_workspace","appointments","court_decisions","portfolio_monitoring","F.01\u002F25\u002F159","2025-06-17","2026-09-29","lack_of_assets","09172969",{"value":35,"source":36},"BV","cir",{"name":38,"slug":39,"location":14},"Rechtbank Oost-Brabant","oost-brabant","mr. S.C.E.F. Moulen Janssen",{"type":36,"report_number":14,"published_on":14},{"name":43,"slug":44,"law_firm":14,"city":14,"verified":45},"mr. D.P. Schalken","dp-schalken",false,{"street":47,"house_number":48,"addition":49,"postal_code":50,"city":51,"municipality":51,"province":52,"lat":53,"lng":54,"kind":55,"source":36},"Kloosterstraat","9","RK","5349AB","Oss","Noord-Brabant",51.760717,5.533719,"business",{"reports":57,"documents":58,"assets":59,"investigations":60,"news":60},9,13,6,0,{"overview":62,"reports":64,"financials":65,"investigations":66,"assets":67,"timeline":68,"documents":69,"news":70,"company":71,"compare":72},{"index":63,"ads":63},true,{"index":63,"ads":63},{"index":63,"ads":63},{"index":45,"ads":45},{"index":63,"ads":45},{"index":45,"ads":45},{"index":45,"ads":45},{"index":45,"ads":45},{"index":45,"ads":45},{"index":45,"ads":45},"2026-08-11","2026-10-04T17:34:33+00:00",{"last_checked_at":76,"last_reconciled_at":77,"stale":45,"status":78},"2026-10-08T16:00:19+00:00","2026-10-01T14:27:10+00:00","current",{"continued_from":14,"continued_as":14},{"data":81},{"summary":82,"changes":149,"kpis":239,"topics":270,"topics_report_number":106,"topics_report_date":107,"processing":14,"timeline":337,"documents":394,"sources":410,"curator_update":14,"news":412,"auctions":413},{"kind":83,"category":83,"sentences":84,"facts":128,"published_at":148},"template",[85,90,93,97,100,110,116,122],{"key":86,"params":87,"facts":88},"declared",{"procedure":9,"date":30,"court":38,"number":29},[89],"procedure",{"key":8,"params":91,"facts":92},{"date":31},[8],{"key":94,"params":95,"facts":96},"curator",{"name":43},[94],{"key":20,"params":98,"facts":99},{"count":57,"number":14,"date":73},[20],{"key":101,"params":102,"facts":108},"value",{"field":103,"value":104,"state":105,"qualifier":14,"number":106,"date":107},"estate_assets",315857.06,"known",4,"2026-04-08",[109],"value_estate_assets",{"key":101,"params":111,"facts":114},{"field":112,"value":113,"state":105,"qualifier":14,"number":106,"date":107},"concurrent_claims",680175.99,[115],"value_concurrent_claims",{"key":101,"params":117,"facts":120},{"field":118,"value":119,"state":105,"qualifier":14,"number":106,"date":107},"creditor_count",21,[121],"value_creditor_count",{"key":101,"params":123,"facts":126},{"field":124,"value":125,"state":105,"qualifier":14,"number":106,"date":107},"preferential_claims",580086.57,[127],"value_preferential_claims",{"company":129,"procedure":131,"terminated":132,"curator":133,"reports":134,"value_estate_assets":135,"value_concurrent_claims":139,"value_creditor_count":142,"value_preferential_claims":145},{"category":130},"official",{"category":130},{"category":130},{"category":130},{"category":130},{"category":136,"value_id":137,"reference_id":138},"automated",45712,372179,{"category":136,"value_id":140,"reference_id":141},13651,318122,{"category":136,"value_id":143,"reference_id":144},13650,318121,{"category":136,"value_id":146,"reference_id":147},13652,318123,"2026-10-08T08:54:00+00:00",{"from":150,"to":154,"count":156,"groups":157},{"id":151,"number":152,"published_on":153},"01M3SJFZZX1K9WBY6WZ9W86CVW",3,"2026-01-14",{"id":155,"number":106,"published_on":107},"01M3SJG4ZHENMD35XVB72FSVJQ",7,{"new":158,"changed":159,"completed":225,"ongoing":237,"no_longer_mentioned":238},[],[160,181,193,205,213,220],{"kind":161,"field":112,"change":162,"from":163,"to":165,"delta":166,"delta_ratio":167,"source":168},"amount","changed",{"value":164,"state":105,"qualifier":14},669975.99,{"value":113,"state":105,"qualifier":14},10200,0.0152,{"id":141,"category":136,"method":169,"source_type":170,"document":171,"page":176,"section":177,"excerpt":178,"certainty":179,"curator_verified_at":14,"processed_at":180},"deterministic","cir_report",{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},"01M3SJG6EV72GZJ4NWXZ6V4RQB","Verslag: 08-04-2026",17,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG6EV72GZJ4NWXZ6V4RQB.pdf",15,"8.6 Bedrag concurrente crediteuren","€ 662.535,77 Toelichting Van dit bedrag bestaat EUR 625.393,20 uit voorafgaand aan faillietverklaring verschuldigde huurpenningen. De huurbetaling w as als gevolg van een eind 2024 gemaakte afspraak met de verhuurder uitgesteld.",0.95,"2026-10-02T18:43:03+00:00",{"kind":182,"field":118,"change":162,"from":183,"to":185,"delta":186,"delta_ratio":187,"source":188},"count",{"value":184,"state":105,"qualifier":14},20,{"value":119,"state":105,"qualifier":14},1,0.05,{"id":144,"category":136,"method":169,"source_type":170,"document":189,"page":190,"section":191,"excerpt":192,"certainty":179,"curator_verified_at":14,"processed_at":180},{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},14,"8.5 Aantal concurrente crediteuren","7",{"kind":194,"topic":195,"change":162,"from":196,"to":197,"source":198},"topic","bookkeeping_duty","investigating","mentioned",{"id":199,"category":136,"method":169,"source_type":170,"document":200,"page":201,"section":202,"excerpt":203,"certainty":204,"curator_verified_at":14,"processed_at":180},318135,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},11,"7.1 Boekhoudplicht","Voldaan.",0.5,{"kind":194,"topic":206,"change":162,"from":196,"to":197,"source":207},"director_liability",{"id":208,"category":136,"method":169,"source_type":170,"document":209,"page":210,"section":211,"excerpt":212,"certainty":204,"curator_verified_at":14,"processed_at":180},318136,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},12,"7.5 Onbehoorlijk bestuur","Toelichting Er is geen sprake van onbehoorlijk bestuur. De gemaakte intercompany-afspraken over de toebedeling van kosten en activa binnen het concern w erd achterhaald door het uitgesproken faillissement van Lead Pharma Holding B.V.",{"kind":194,"topic":214,"change":162,"from":196,"to":197,"source":215},"paulianas",{"id":216,"category":136,"method":169,"source_type":170,"document":217,"page":210,"section":218,"excerpt":219,"certainty":204,"curator_verified_at":14,"processed_at":180},318137,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},"7.6 Paulianeus handelen","Nee Toelichting Er is geen sprake van paulianeus handelen.",{"kind":194,"topic":221,"change":162,"from":196,"to":197,"source":222},"legality_review",{"id":223,"category":136,"method":169,"source_type":170,"document":224,"page":201,"section":202,"excerpt":203,"certainty":204,"curator_verified_at":14,"processed_at":180},318138,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},[226],{"kind":194,"topic":227,"change":228,"from":197,"to":228,"source":229},"causes_investigation","completed",{"id":230,"category":136,"method":169,"source_type":170,"document":231,"page":232,"section":233,"excerpt":234,"certainty":235,"curator_verified_at":14,"processed_at":236},134802,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},5,"1.5 Oorzaak faillissement","Tot heden is de curator het volgende gebleken uit gesprekken met het bestuur en betrokkenen, maar dit vormt geen conclusie. Lead Pharma Medicine B.V. exploiteert een farmaceutisch onderzoeks- en ontw ikkelbedrijf. Daartoe verricht zij onderzoek naar nieuw e medicijnen ter genezing van kanker en auto-immuunziekten. Medicijnonderzoek is een langdurig en kostbaar traject. Van een idee naar verkoop du",0.7,"2026-09-30T16:31:29+00:00",[],[],{"values":240,"reports":269},[241,252,256,262,266],{"field":103,"kind":161,"value":104,"state":105,"qualifier":14,"as_of":107,"category":136,"report_number":106,"report_date":107,"source":242,"previous":249,"delta":251,"curator":14,"processing":63,"correction_pending":45,"conflict":14},{"id":138,"category":136,"method":169,"source_type":170,"document":243,"page":59,"section":247,"excerpt":248,"certainty":179,"curator_verified_at":14,"processed_at":74},{"id":244,"title":245,"report_number":106,"report_date":107,"published_on":107,"page_count":57,"url":246,"available":63},"01M3SJG4YYAPBHX0ZT5CMQ61T4","Financieel verslag 08-04-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG4YYAPBHX0ZT5CMQ61T4.pdf","financial_statement_a","Totaal baten                                         € 315.857,06                      € 54.548,53",{"value":250,"state":105,"report_number":152,"report_date":153},315647.65,209.41,{"field":112,"kind":161,"value":113,"state":105,"qualifier":14,"as_of":107,"category":136,"report_number":106,"report_date":107,"source":253,"previous":255,"delta":166,"curator":14,"processing":63,"correction_pending":45,"conflict":14},{"id":141,"category":136,"method":169,"source_type":170,"document":254,"page":176,"section":177,"excerpt":178,"certainty":179,"curator_verified_at":14,"processed_at":180},{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},{"value":164,"state":105,"report_number":152,"report_date":153},{"field":124,"kind":161,"value":125,"state":105,"qualifier":14,"as_of":107,"category":136,"report_number":106,"report_date":107,"source":257,"previous":261,"delta":60,"curator":14,"processing":63,"correction_pending":45,"conflict":14},{"id":147,"category":136,"method":169,"source_type":170,"document":258,"page":190,"section":259,"excerpt":260,"certainty":179,"curator_verified_at":14,"processed_at":180},{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},"8.2 Pref. vord. van de fiscus","€ 193.905,00 Toelichting Dit bedrag zal nog verder oplopen.",{"value":125,"state":105,"report_number":152,"report_date":153},{"field":118,"kind":182,"value":119,"state":105,"qualifier":14,"as_of":107,"category":136,"report_number":106,"report_date":107,"source":263,"previous":265,"delta":186,"curator":14,"processing":63,"correction_pending":45,"conflict":14},{"id":144,"category":136,"method":169,"source_type":170,"document":264,"page":190,"section":191,"excerpt":192,"certainty":179,"curator_verified_at":14,"processed_at":180},{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},{"value":184,"state":105,"report_number":152,"report_date":153},{"field":267,"kind":182,"value":14,"state":268,"qualifier":14,"as_of":14,"category":14,"report_number":14,"report_date":14,"source":14,"previous":14,"delta":14,"curator":14,"processing":63,"correction_pending":45,"conflict":14},"employee_count","not_mentioned",{"count":57,"next":14},[271,278,281,288,295,303,310,313,320,323,326,334],{"topic":272,"investigation":45,"state":197,"category":136,"source":273},"lease_contracts",{"id":274,"category":136,"method":169,"source_type":170,"document":275,"page":106,"section":276,"excerpt":277,"certainty":204,"curator_verified_at":14,"processed_at":180},318127,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},"1.4 Huur","Afgelopen verslagperiode is een schikking bereikt met de verhuurder over de oplevering, de vaststelling van de diverse vorderingen en de afrekening van 4 de zekerhedenpositie.",{"topic":227,"investigation":63,"state":228,"category":136,"source":279},{"id":230,"category":136,"method":169,"source_type":170,"document":280,"page":232,"section":233,"excerpt":234,"certainty":235,"curator_verified_at":14,"processed_at":236},{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},{"topic":282,"investigation":45,"state":197,"category":136,"source":283},"employees",{"id":284,"category":136,"method":169,"source_type":170,"document":285,"page":59,"section":286,"excerpt":287,"certainty":204,"curator_verified_at":14,"processed_at":236},134803,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},"2.3 Ontslagaanzegging","Datum Aantal Toelichting 20-6-2025 18 totaal 18",{"topic":289,"investigation":45,"state":197,"category":136,"source":290},"asset_sales",{"id":291,"category":136,"method":169,"source_type":170,"document":292,"page":59,"section":293,"excerpt":294,"certainty":204,"curator_verified_at":14,"processed_at":236},134804,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},"3.1 Onroerende zaken","Beschrijving Verkoopopbr. Hypotheek Boedelbijdr. N.v.t. totaal € 0,00 € 0,00 Toelichting onroerende zaken",{"topic":296,"investigation":45,"state":197,"category":136,"source":297},"receivables_collection",{"id":298,"category":136,"method":169,"source_type":170,"document":299,"page":300,"section":301,"excerpt":302,"certainty":204,"curator_verified_at":14,"processed_at":236},134809,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},8,"4.1 Debiteuren","Beschrijving Omvang Opbrengst Boedelbijdr. N.v.t. totaal € 0,00 € 0,00 € 0,00 Toelichting debiteuren Failliet is afhankelijk van investeerders en overheidsinstellingen. Er w erden geen facturen gestuurd.",{"topic":304,"investigation":45,"state":197,"category":136,"source":305},"security_rights",{"id":306,"category":136,"method":169,"source_type":170,"document":307,"page":57,"section":308,"excerpt":309,"certainty":204,"curator_verified_at":14,"processed_at":180},318129,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},"5.3 Beschrijving zekerheden","Er is een schikking bereikt met de pandhouder c.q. verhuurder, die inmiddels ook is uitgevoerd. Dit is dus afgerond.",{"topic":195,"investigation":63,"state":197,"category":136,"source":311},{"id":199,"category":136,"method":169,"source_type":170,"document":312,"page":201,"section":202,"excerpt":203,"certainty":204,"curator_verified_at":14,"processed_at":180},{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},{"topic":314,"investigation":63,"state":228,"category":136,"source":315},"annual_accounts_filing",{"id":316,"category":136,"method":169,"source_type":170,"document":317,"page":210,"section":318,"excerpt":319,"certainty":235,"curator_verified_at":14,"processed_at":236},134817,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},"7.2 Depot jaarrekeningen","De jaarrekening 2023 is gedeponeerd op 4 juli 2024.",{"topic":206,"investigation":63,"state":197,"category":136,"source":321},{"id":208,"category":136,"method":169,"source_type":170,"document":322,"page":210,"section":211,"excerpt":212,"certainty":204,"curator_verified_at":14,"processed_at":180},{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},{"topic":214,"investigation":63,"state":197,"category":136,"source":324},{"id":216,"category":136,"method":169,"source_type":170,"document":325,"page":210,"section":218,"excerpt":219,"certainty":204,"curator_verified_at":14,"processed_at":180},{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},{"topic":327,"investigation":63,"state":197,"category":136,"source":328},"proceedings",{"id":329,"category":136,"method":169,"source_type":170,"document":330,"page":331,"section":332,"excerpt":333,"certainty":204,"curator_verified_at":14,"processed_at":236},134820,{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},16,"9.1 Naam wederpartijen","Er is niet gebleken van procedures.",{"topic":221,"investigation":63,"state":197,"category":136,"source":335},{"id":223,"category":136,"method":169,"source_type":170,"document":336,"page":201,"section":202,"excerpt":203,"certainty":204,"curator_verified_at":14,"processed_at":180},{"id":172,"title":173,"report_number":106,"report_date":107,"published_on":107,"page_count":174,"url":175,"available":63},[338,348,353,361,368],{"id":339,"type":340,"group":89,"category":130,"occurred_at":341,"detected_at":342,"date_basis":343,"payload":344,"from_case":14,"source":14},"01M3SJFSMMPXYSF57HT2H28SJG","publication_added","2026-09-30T00:00:00+00:00","2026-09-30T16:31:13+00:00","source",{"publication_id":345,"type":346,"description":347},"01M3SJFSM4FTZCD4RW2MVXCTP3","termination","Opheffing faillissement wegens gebrek aan baten op 29 september 2026",{"id":349,"type":350,"group":89,"category":130,"occurred_at":351,"detected_at":342,"date_basis":343,"payload":352,"from_case":14,"source":14},"01M3SJFSMQX323HXVS9X469T2G","case_terminated","2026-09-29T00:00:00+00:00",{"status":8,"reason":32},{"id":354,"type":355,"group":20,"category":130,"occurred_at":356,"detected_at":357,"date_basis":343,"payload":358,"from_case":14,"source":14},"01M3SJG819ESJGTAAKMA93J97Z","report_published","2026-08-11T12:00:00+00:00","2026-09-30T16:31:28+00:00",{"report_id":359,"report_number":14,"report_date":73,"title":360,"is_final":45},"01M3SJG6FEAWMH3848H04YH4D5","Financieel verslag  04-08-2026",{"id":362,"type":340,"group":89,"category":130,"occurred_at":363,"detected_at":342,"date_basis":343,"payload":364,"from_case":14,"source":14},"01M3SJFSMHNTZBKNQ3HZNMJF2C","2026-05-13T00:00:00+00:00",{"publication_id":365,"type":366,"description":367},"01M3SJFSM3Z6MEWKZGNM4HV5W9","other","Vereenvoudigde afwikkeling van het faillissement",{"id":369,"type":370,"group":371,"category":136,"occurred_at":372,"detected_at":74,"date_basis":343,"payload":373,"from_case":14,"source":14},"01M43ZPMHXVZN6717B8YS6EP76","financial_changed","financial","2026-04-08T12:00:00+00:00",{"from_report":374,"to_report":375,"from_number":152,"to_number":106,"from_date":153,"to_date":107,"fields":376},"01M3SJG1NNPSYYN830PZWANSXG","01M3SJG386F9XHFPVQ99ZCXF6P",[377,380,387],{"field":103,"from":378,"to":379,"delta":251},{"value":250,"state":105,"qualifier":14},{"value":104,"state":105,"qualifier":14},{"field":381,"from":382,"to":384,"delta":386},"estate_claims",{"value":383,"state":105,"qualifier":14},820,{"value":385,"state":105,"qualifier":14},248327.33,247507.33,{"field":388,"from":389,"to":391,"delta":393},"estate_account_balance",{"value":390,"state":105,"qualifier":14},285544.57,{"value":392,"state":105,"qualifier":14},164753.98,-120790.59,[395,400,405,409],{"kind":396,"id":345,"title":347,"report_number":14,"date":397,"pages":14,"category":130,"url":14,"publication_type":346,"publication_number":398,"stored_at":342,"download_url":399},"publication","2026-09-30","01.obr.25.159.F.1316.1.26","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Flead-pharma-medicine-bv-09172969\u002Fpublications\u002F01M3SJFSM4FTZCD4RW2MVXCTP3\u002Fdownload",{"kind":401,"id":402,"title":360,"report_number":14,"report_date":73,"date":73,"pages":403,"category":130,"url":404},"report","01M3SJG816Q8VPXB9KRPS86W8P",10,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG816Q8VPXB9KRPS86W8P.pdf",{"kind":396,"id":365,"title":367,"report_number":14,"date":406,"pages":14,"category":130,"url":14,"publication_type":366,"publication_number":407,"stored_at":342,"download_url":408},"2026-05-13","01.obr.25.159.F.1308.1.26","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Flead-pharma-medicine-bv-09172969\u002Fpublications\u002F01M3SJFSM3Z6MEWKZGNM4HV5W9\u002Fdownload",{"kind":401,"id":172,"title":173,"report_number":106,"report_date":107,"date":107,"pages":174,"category":130,"url":175},{"official":58,"curator":60,"automated":411,"external":60},74,[],[]]